Luye Pharma Group Ltd. has announced the conversion of its Tranche A Bonds, originally issued in the principal amount of US$100,000,000 with a 5.85% interest rate, due in 2025. On August 1, 2025, bonds amounting to US$10,000,000 were converted into shares at a conversion price of HK$3.672 per share. This conversion resulted in the issuance of approximately 21,167,755 new shares, representing around 0.563% of the company's issued share capital before the conversion and approximately 0.560% after. Following this transaction, the outstanding principal of the Tranche A Bonds stands at US$90,000,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Luye Pharma Group Ltd. published the original content used to generate this news brief on August 01, 2025, and is solely responsible for the information contained therein.